. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA Neurol. 2014 Jul 1;71(7):855-62. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(547)
490 ± 176
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
Aβ42
(CSF)
VaD
(30)
638 ± 233
pg/mL
ELISA;
Innotest;
Innogenetics
Román et al., 1993
tau-p181
(CSF)
AD
(547)
89 ± 40
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-p181
(CSF)
VaD
(30)
42 ± 19
pg/mL
ELISA;
Innotest;
Innogenetics
Román et al., 1993
tau-total
(CSF)
AD
(547)
692 ± 404
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
VaD
(30)
312 ± 180
pg/mL
ELISA;
Innotest;
Innogenetics
Román et al., 1993

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

AlzBiomarker

  1. VaD vs AD : Aβ42 (CSF)
  2. VaD vs AD : tau-p181 (CSF)
  3. VaD vs AD : tau-total (CSF)